Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pachai Natarajan
Institution:
MaxCyte (United States)
Observed institutions:
MaxCyte (United States),
Avalon Pharma (United States)
OpenAlex ID:
A5112306493
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
2017
·
Suk See De Ravin
, Linhong Li
, et al.
·
Science Translational Medicine
·
277
Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy
2018
·
Chien-Fu Hung
, Xuequn Xu
, et al.
·
Human Gene Therapy
·
86
Reexamination of the Effect of Endotoxin on Cell Proliferation and Transfection Efficiency
2000
·
Kimberly A. Butash
, Pachai Natarajan
, et al.
·
BioTechniques
·
53
PDF
Antiangiogenic properties of the IMPDH inhibitor AVN944
2007
·
Zoë Weaver Ohler
, Jeffrey Strovel
, et al.
·
Cancer Research
·
2
Highly efficient and specific genome editing in human cells with paired CRISPR-Cas9 nickase ribonucleoproteins
2019
·
Jacob Lamberth
, Laura Daley
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract 3748: Development of anti-human mesothelin chimeric antigen receptor (CAR) messenger RNA (mRNA) transfected peripheral blood mononuclear cells (CARMA) for the treatment of mesothelin-expressing cancers
2017
·
Chien-Fu Hung
, Xuequn Xu
, et al.
·
Cancer Research
MaxCyte scalable electroporation: A universal cell engineering platform for development of cell-based medicines from R&D to clinic
2017
·
Jessica McClure-Kuhar
, J. Turnay Abad
, et al.
41. Therapeutic Level CRISPR-Oligomer-Mediated Correction of X-CGD Patient Hematopoietic Stem Cells Using Non-Viral, cGMP Compliant, Scalable, and Closed System
2016
·
Linhong Li
, Suk see De Ravin
, et al.
·
Molecular Therapy
PDF
Seamless scalability, consistency and quality of transient protein production in CHO Cells by using MaxCyte flow electroporation technology
2016
·
Weili Wang
, Rama Shivakumar
, et al.
Rapid Production of Recombinant Proteins in CHO Cells using MaxCyte's Scalable Flow Electroporation Technology
2016
·
B. Whitney James
, Weili Wang
, et al.
·
Program & Abstracts. Annual and International Meeting of the Japanese Association for Animal Cell Technology
Development of ‘enhanced’ potency immunotherapy products using nonviral approaches
2015
·
James Brady
, Linhong Li
, et al.
·
Pharmaceutical Bioprocessing
299. Efficient Functional Oxidase Correction after CRISPR-Oligomer Gene Repair in X-CGD Patient Hematopoietic Stem Cells (HSC) Using Non-Viral, cGMP Compliant, Scalable, Closed System
2015
·
Linhong Li
, Suk see De Ravin
, et al.
·
Molecular Therapy
PDF
Characterization of a myeloid leukemia cell line resistant to inosine monophosphate dehydrogenase (IMPDH) inhibition: correlation of molecular pathway markers and GTP depletion with clinical biomarkers.
2008
·
Jeffrey Strovel
, Tammy Lawrence
, et al.
·
Cancer Research
In Vitro Characterization of Wnt/β-Catenin Pathway Inhibition in Multiple Myeloma Cell Lines Using a Novel Class of Small Molecules.
2007
·
Jeffrey W. Strovel
, Tammy Lawrence
, et al.
·
Blood
LC-363: Optimization and in vitro characterization of a novel series of small molecule inhibitors of the Wnt/β-catenin signaling pathway.
2007
·
Jeffrey Strovel
, Irina Lonskaya
, et al.
·
Molecular Cancer Therapeutics
Towards personalized medicine: Utilizing biomarkers to track response of the inosine monophosphate dehydrogenase (IMPDH) inhibitor AVN944 patient samples from a Phase I clinical trial in AML and evaluation of a patient stratification signature.
2007
·
Jeffrey Strovel
, J. Michael Hamilton
, et al.
·
Clinical Cancer Research
Genetic and Biochemical Biomarkers of IMPDH Inhibition in Phase I Dose Escalation of AVN-944 for Hematologic Malignancies.
2006
·
Jeffrey W. Strovel
, Marion Chakiath
, et al.
·
Blood
Biomarker-driven drug discovery: Identification and characterization of small molecule inhibitors against beta-catenin and Aurora kinase
2006
·
Paul E. Young
, Steve Horrigan
, et al.
·
Cancer Research
Identification of a predictive efficacy signature from microarray analysis of human tumor xenografts treated with anticancer compounds.
2004
·
David K. Bol
, Zoë Weaver Ohler
, et al.
·
Cancer Research
Show more works
View as search
Works count:
19
Citation count:
419
H-index:
3
I10-index:
3
Year
Topic
Type